Report cards › Food › UTZ Quality Foods, LLC

UTZ

Owned by UTZ Quality Foods, LLC · 494 products in USDA FoodData Central · as of Oct 28, 2026 · Report an error · Change log

CSWH grade B (78)

Method v1.0 (how we grade), based on the records below; exact score 77.9777.

Grade by indicator
IndicatorGradeWhat we found
Recalls (40%)C (60)1 Class I (10 points) · 1 event For current recalls see FDA and USDA.
Ingredients (40%)A (85)Tier A: 2 of 494 products (FD&C Red No. 3) · A (98) (25%)
Tier B: 109 of 494 products (FD&C Yellow No. 6, FD&C Yellow No. 5, FD&C Red No. 40, FD&C Blue No. 1, Partially hydrogenated oil (PHO), DATEM and 4 more) · C (63) (15%) · products
FDA warning letters (20%)A (100)None found to the owner Oct 28, 2021 to Oct 28, 2026.

Shown, not graded: recall reasons (1 undeclared allergen) · IARC notes (0 products) · FDA dye pledge: none on FDA's tracker.

Recalls, Oct 28, 2021 to Oct 28, 2026

  1. Class I, Jan 25, 2024 · Undeclared allergen · FDA event 93884

    • Utz Wavy Originals Potato Chips, Net WT. 2.75 oz (78g), UPC 0-41780-19014-7.

      Reason (FDA's words)
      Product may contain undeclared milk.
      Code information
      o May062024 o 23363020302
      Recalling firm
      UTZ QUALITY FOODS, LLC
      Dates
      Recall started Jan 25, 2024; classified Feb 9, 2024
      Status
      Terminated (status reported by FDA at classification)
      How we matched it
      matched by UPC 41780190147 (upc)

      FDA record F-0866-2024: openFDA · Report an error

1 recall event by UTZ Quality Foods, LLC name no brand, so it is on the owner's page, not counted here.

Store-brand and co-packer recalls count on a brand only when a UPC in the recall matches one of its products.

Ingredients on our watch list

Products (109)

Show all 109 products

Labels change: each row shows the date of its FoodData Central record. A brand that has changed a recipe can report it with "Report an error".

FDA warning letters to UTZ Quality Foods, LLC, Oct 28, 2021 to Oct 28, 2026

None found from FDA food offices.

FDA notes that later events may have changed the regulatory status of what a letter discusses.